BIOMAT Database Logo BIOMAT Database Logo

In vitro FK 506 kidney tubular cell toxicity. 1991

A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
Department of Urology, Osaka University, Japan.

UI MeSH Term Description Entries
D007684 Kidney Tubules Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER. Kidney Tubule,Tubule, Kidney,Tubules, Kidney
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
Kidney transplantation under FK 506.
July 1990, JAMA,
A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
FK 506: long-term study in kidney transplantation. Japanese FK 506 Study Group.
February 1995, Transplantation proceedings,
A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
Toxicity of FK 506 in the cynomolgus monkey: noncorrelation with FK 506 serum levels.
December 1991, Transplantation proceedings,
A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
FK 506 in clinical kidney transplantation.
December 1991, Transplantation proceedings,
A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
Tacrolimus (FK 506) in kidney transplantation.
August 1998, Transplantation proceedings,
A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
Tacrolimus (FK-506) in kidney transplantation.
January 1997, Transplantation proceedings,
A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group.
February 1995, Transplantation proceedings,
A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
Kidney transplantation under FK 506 immunosuppression.
February 1991, Transplantation proceedings,
A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
Toxicity of FK-506 in human fetal pancreas.
January 1989, Diabetes,
A Moutabarrik, and M Ishibashi, and H Kameoka, and A Ogata, and N Kawaguchi, and Y Takano, and Y Kokado, and S Takahara, and H Jiang, and S Onishi
FK 506 affects platelet aggregation in vitro.
July 1994, Thrombosis research,
Copied contents to your clipboard!